Breaking News
Get 60% Off 0
🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…
CLAIM SALE
Close

Seligson & Co Global Top 25 Pharmaceuticals Fund B (0P00000NG2)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
18.323 -0.002    -0.01%
26/11 - Delayed Data. Currency in EUR
Type:  Fund
Market:  Finland
ISIN:  FI0008801998 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 271.45M
Seligson & Co Global Top 25 Pharmaceuticals B 18.323 -0.002 -0.01%

0P00000NG2 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Seligson & Co Global Top 25 Pharmaceuticals B (0P00000NG2) fund. Our Seligson & Co Global Top 25 Pharmaceuticals B portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.280 0.280 0.000
Shares 99.720 99.720 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 14.417 21.195
Price to Book 3.368 4.173
Price to Sales 3.224 2.490
Price to Cash Flow 14.034 17.334
Dividend Yield 2.720 1.320
5 Years Earnings Growth 15.150 13.721

Sector Allocation

Name  Net % Category Average
Healthcare 100.000 94.960

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Developed Markets

Top Holdings

Number of long holdings: 26

Number of short holdings: 0

Name ISIN Weight % Last Change %
  Novartis CH0012005267 6.97 91.99 +0.07%
  Roche Holding Participation CH0012032048 6.95 251.50 +0.04%
  J&J US4781601046 6.55 154.52 -0.01%
  Pfizer US7170811035 6.39 25.77 -1.53%
  Merck&Co US58933Y1055 6.21 101.62 +0.45%
  Eli Lilly US5324571083 4.51 789.32 +4.55%
  AbbVie US00287Y1091 4.15 181.14 +2.30%
  Chugai Pharmaceutical JP3519400000 4.07 6,576.0 +3.15%
  Daiichi Sankyo JP3475350009 3.83 4,642.0 +2.02%
  Vertex US92532F1003 3.72 467.07 +1.16%

Top Equity Funds by Seligson & Co Rahastoyhtiö Oyj

  Name Rating Total Assets YTD% 3Y% 10Y%
  Seligson & Co Global Top 25 Brands 713.69M 8.06 5.52 11.64
  Seligson Co Global Top 25 Brands Fu 713.69M 8.06 5.53 11.68
  Seligson North American B 534.76M 26.69 13.09 14.29
  Seligson & Co North American A 534.76M 26.70 13.09 14.31
  FI4000283031 385.74M 25.38 13.01 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00000NG2 Comments

Write your thoughts about Seligson & Co Global Top 25 Pharmaceuticals Fund B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email